Specialty Pharmaceutical Leadership
Stephen Corba, Pharmaceutical Distribution Leader
Stephen Corba is a pharmaceutical distribution executive with over two decades of experience leading specialty supply solutions that support clinical trials, ensure regulatory compliance, and secure access to critical medicines.
Professional Background & Leadership
Professional Presence
Executive Leadership in Pharmaceutical Distribution
Stephen Corba is a pharmaceutical distribution executive with more than two decades of experience supporting clinical research, specialty drug sourcing, and regulatory-compliant supply chains. His career spans global pharmaceutical sales, distribution leadership, and executive entrepreneurship.
After early roles at AstraZeneca, Stephen advanced into senior leadership positions where he developed deep expertise in clinical trial logistics, comparator sourcing, and navigating drug shortages. In 2011, he founded Investigational Drug Delivery (IDD) to address one of clinical research’s most critical challenges—reliable access to hard-to-source medicines.
Today, through IDD and his leadership role at VRC Medical Services, Stephen focuses on building trusted partnerships that enable research teams to operate efficiently, compliantly, and without interruption. His work reflects a consistent commitment to patient safety, operational precision, and long-term collaboration across the healthcare ecosystem.
- 20+ years in pharmaceutical distribution
- Founder & CEO, Investigational Drug Delivery
- Executive Director, VRC Medical Services
- Clinical trial and comparator sourcing expertise
Founded & Led
The Brands I’ve Founded and Led
AminoQuest Labs
Role: Founder / Principal
AminoQuest Labs supplies GMP-sourced, rigorously tested peptides for research and development, partnering with certified manufacturers to deliver consistent quality, documentation transparency, and dependable global fulfillment for scientific and laboratory applications.
Investigational Drug Delivery LLC (IDD)
Role: Founder, President & CEO
Founded in 2011, Investigational Drug Delivery supports clinical trials by sourcing hard-to-access comparator drugs and specialty pharmaceuticals, helping research teams overcome shortages while maintaining regulatory compliance and supply chain integrity.
Medroxy4Less
Role: Founder
Medroxy4Less provides licensed healthcare providers with access to FDA-approved generic Medroxyprogesterone Acetate injectable products, offering compliant sourcing, transparent pricing, and cost-conscious solutions that help reduce healthcare and patient expenses.
VRC Medical Services
Past Role: Executive Director
VRC Medical Services is a licensed pharmaceutical wholesaler providing compliant comparator drugs, clinical supplies, and distribution services worldwide, supporting hospitals, research organizations, and healthcare systems with reliable sourcing and regulatory-aligned logistics.
Media Coverage
Featured In Leading Global Publications
Focus & Impact
Advancing Clinical Research Through Comparator Drug Access
Much of my work focuses on comparator drug sourcing for clinical trials — a critical but often overlooked component of pharmaceutical research. Reliable access to reference medications enables competition, supports biosimilar and generic development, and helps reduce long-term drug costs across the U.S. healthcare system.
Through Investigational Drug Delivery and VRC Medical Services, I’ve worked with research organizations, CROs, and healthcare partners to navigate shortages, diversify sourcing strategies, and maintain regulatory compliance. These efforts support clinical trial continuity and align with national priorities aimed at lowering prescription drug costs. Industry data shows that expanded comparator access and biosimilar adoption have contributed to more than $38 billion in U.S. healthcare savings over recent years — impact made possible by functional supply chain infrastructure behind the scenes.
- Comparator sourcing for clinical trials and biosimilar development
- Drug shortage mitigation through diversified procurement strategies
- Regulatory-compliant supply chains supporting long-term cost reduction
This work aligns with federal initiatives focused on increasing competition and lowering prescription drug costs, including the Trump Administration’s RX initiative.
Insights & Perspectives
Advancing Clinical Research Through Reliable Access
Strategic perspectives on comparator sourcing, drug affordability, and the infrastructure required to support reliable, compliant clinical research worldwide.
DSCSA Compliance in 2026: What the Rules Require Now
In my work across pharmaceutical distribution and clinical research, I have watched the Drug Supply Chain Security Act quietly reshape how prescription medicines move through the United States, and 2026
Biosimilar Interchangeability Explained: What It Means and Why It Is Changing
In more than fifteen years working on the infrastructure behind clinical research, I have found that few topics in the biologics conversation cause as much confusion as biosimilar interchangeability. The
What Is a Comparator Drug? A Plain Guide for Clinical Research
If you follow clinical research, you will run into the term comparator drug quickly, and it is not always explained well. Much of my work involves making sure these products